Industrials·Aerospace & Defense·$81.7B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.14 | N/A | +22.92% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $2.14 | N/A | +22.92% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a sense of cautious optimism about future opportunities. They acknowledged market challenges but emphasized their commitment to growth.
Management highlighted strong performance in defense contracts.
They noted ongoing challenges in the market but expressed confidence in their strategic direction.
Northrop Grumman's earnings report shows a solid beat on EPS, indicating better-than-expected profitability. However, the stock reacted negatively, declining by 0.64%, likely due to the absence of revenue figures and forward guidance. Investors may be cautious given the current market challenges mentioned by management.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
BIOGEN INC
Jan 28, 2013